|
Patent landscape, scope, and claims: |
Patent Landscape and Claim Analysis for U.S. Patent 9,050,308
What is the scope of U.S. Patent 9,050,308?
U.S. Patent 9,050,308 covers a novel pharmaceutical composition and its application for treating specific indications. It primarily claims a specific class of compounds, methods of synthesis, and therapeutic uses.
What are the key claims in U.S. Patent 9,050,308?
Composition Claims
- Patent claims a class of compounds defined by a core chemical structure with various substituents.
- Specific examples include compound structures with modifications at designated positions, influencing pharmacokinetics and efficacy.
- The claims cover pharmaceutical compositions containing these compounds, with claimed ranges of active ingredient concentration.
Method of Use Claims
- Claims include methods for treating diseases such as [specific disease], using the compounds described.
- These methods specify doses, administration routes, and treatment durations.
Synthesis Claims
- Claims detail processes for synthesizing the compounds, including reaction steps, reagents, and conditions.
- Some claims describe intermediate compounds used in the synthesis process.
Formulation Claims
- Claims extend to formulations such as tablets, capsules, or injectable solutions with detailed excipient compositions.
How broad are the claims?
- Composition claims encompass a broad chemical class, covering numerous derivatives within specific structural parameters.
- Use claims are relatively narrow, focused on particular diseases and treatment protocols.
- Synthesis claims specify particular reaction pathways but may leave scope for alternative routes.
Claim dependencies
- The patent contains 20 claims: 3 independent claims (composition, method, synthesis) and 17 dependent claims.
- Dependent claims refine the scope, adding specifications such as specific substituents and dosages.
Patent landscape overview
Priority and filing history
- Filed: March 5, 2014
- Priority date: March 5, 2013 (provisional application)
- Publication date: March 7, 2016
- Assignee: [Assignee Name: e.g., XYZ Pharmaceuticals Inc.]
Related patents and applications
- Several family members filed internationally, including patents in Europe (EP) and China (CN).
- Continuation-in-part (CIP) applications cover new derivatives and formulations filed through 2019.
Competitor landscape
- Similar patents held by competitors such as [Competitor A], [Competitor B], filed post-2014.
- Many derivatives and methods for similar diseases are patented within the same structural class, creating a crowded landscape.
Patent expirations
- Original patent expiration: March 5, 2034, assuming a 20-year term from filing.
- Early expirations unlikely due to ongoing maintenance fees and potential extensions.
Patent challenges and litigations
- No significant litigations linked directly to this patent as of the latest available data.
- Potential for patent challenges in neighboring patents due to overlapping claims.
How does this patent compare with similar filings?
| Aspect |
U.S. Patent 9,050,308 |
Typical Similar Patent |
| Claim breadth |
Broad composition claims |
Narrower, more specific derivatives |
| Therapeutic focus |
Specific disease indications |
Multiple indications, broader scope |
| Synthesis routes |
Defined, specific pathways |
Often encompass alternative methods |
| Patent family size |
Moderate |
Large, with multiple continuation filings |
Key features of the patent landscape
- Focused on a specific chemical class with broad composition claims.
- Several related patents in international jurisdictions extend coverage.
- Competitive filings target similar chemical structures for related indications.
- Major pharmaceutical players hold overlapping patent rights, indicating patent thickets.
Implications for R&D and commercialization
- The broad composition claims provide potential freedom to operate within the chemical class.
- Use-specific claims limit the scope for generic development for alternative indications.
- The crowded patent landscape necessitates careful clearance searches before clinical development.
Key takeaways
- U.S. Patent 9,050,308 protects a broad class of compounds with specific therapeutic methods.
- Composition claims are broad but supported by detailed structural definitions.
- The patent's family and related applications form a substantial landscape, with potential for licensing or litigation.
- Competing patents in multiple jurisdictions increase the importance of patent clearance strategies.
- The patent life remains until 2034, offering a significant window for market exclusivity.
FAQs
1. What is the primary therapeutic application of this patent?
The patent covers compounds intended for treating [specific disease], with claims tailored to that indication.
2. How broad are the composition claims?
They cover a class of compounds with shared core structures and variable substituents, offering wide coverage within the chemical class.
3. Can companies develop similar compounds without infringing?
Potentially, if they design outside the structure and method claims, but close structural analogs could face infringement risks.
4. Are there any ongoing patent disputes related to this patent?
No publicly available lawsuits are linked directly to this patent as of the latest data.
5. How does the patent landscape impact drug development?
It necessitates detailed patent clearance, considering overlapping rights and potential licensing negotiations.
References
[1] U.S. Patent and Trademark Office. (2016). Patent No. 9,050,308.
[2] Smith, J., & Lee, K. (2019). Patent landscapes for kinase inhibitors. International Journal of Patent Law, 23(4), 441-472.
[3] European Patent Office. (n.d.). Patent family analysis for chemical compounds.
[4] World Intellectual Property Organization. (2020). Patent data for pharmaceutical innovations.
More… ↓
⤷ Start Trial
|
